EcoDrugPlus

Ensembl ID : ENSVPAG00000006021
Gene Symbol: -
Cross references: -
162 Possible Orthologues:

Ensembl ID : ENSVPAG00000005970
Gene Symbol: -
Cross references: -
240 Possible Orthologues:

Ensembl ID : ENSVPAG00000005917
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSVPAG00000005097
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSVPAG00000005022
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSVPAG00000004837
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSVPAG00000004123
Gene Symbol: -
Cross references: -
160 Possible Orthologues:

Ensembl ID : ENSVPAG00000003428
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSVPAG00000003348
Gene Symbol: -
Cross references: -
282 Possible Orthologues:

Ensembl ID : ENSVPAG00000003195
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSVPAG00000002569
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSVPAG00000002137
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).